Anavex Life Sciences Corp (AVXL)
Operating Cash Flow Growth
-8.60%
Quarterly · Period ending:
AVXL Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-8.60%period ending
Latest reported-8.60%period ending
AVXL Quarterly Cash from Operations YoY % (0.00% → -8.60%)
Year-over-year change
High-resolution chart · PNG
AVXL operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -8.6008% | |
| 24.1803% | |
| 40.9983% | |
| -29.228% | |
| -140.6178% | |
| 49.7598% | |
| -65.619% | |
| -13.8192% | |
| 32.3141% | |
| -37.3071% | |
| -26.3031% | |
| -44.6519% | |
| -8.4995% | |
| 11.9351% | |
| -65.4977% | |
| 47.3069% | |
| 6.2154% | |
| -31.7437% | |
| 55.523% | |
| -22.6984% | |
| -85.9676% | |
| -39.0271% | |
| -37.4875% | |
| -146.8041% | |
| 46.0855% | |
| -21.5039% | |
| -37.6184% | |
| 37.4735% | |
| -259.2291% | |
| -53.5451% | |
| -14.9176% | |
| -84.9174% | |
| 29.7865% | |
| -304.2994% | |
| -14.7927% | |
| -17.6365% | |
| -33.7337% | |
| 63.3261% | |
| 2.8814% | |
| -29.993% | |
| -55.4788% | |
| -183.8447% | |
| -368.5229% | |
| -56.3343% | |
| -48.9884% | |
| -92.8705% | |
| -59.3301% | |
| -89.2342% | |
| -2,882.3082% | |
| -168.7731% | |
| -230.6073% | |
| -92.3162% | |
| 86.5146% | |
| -13.242% | |
| 87.9083% | |
| 72.6928% | |
| 80.2069% | |
| 80.6124% | |
| -0.384% | |
| 44.5422% | |
| -9.7301% | |
| 43.9633% | |
| -38.9765% | |
| -71.2668% | |
| 6.9696% | |
| -181.3131% | |
| -190.6784% | |
| -27.0638% | |
| -97.7023% | |
| 14.2326% | |
| 60.3331% | |
| -1,172.1149% | |
| -194.5028% | |
| -699.3541% | |
| -8,618.1724% | |
| -45.6059% | |
| -847.7024% | |
| -216.6783% | |
| -614.4567% | |
| -100.9201% | |
| 56.3747% | |
| 0% |